Today: 3 April 2026
Barclays share price edges up as £500m buyback ends and BoE rate call nears
4 February 2026
1 min read

Barclays share price edges up as £500m buyback ends and BoE rate call nears

London, Feb 4, 2026, 08:32 GMT — Regular session

  • Shares of Barclays edged up roughly 0.3% in early London trading. The bank is set to release its full-year results on Feb. 10.
  • The bank has wrapped up a share buyback totaling about £500 million, cancelling over 107 million shares in the process
  • Investors are focused on the Bank of England’s Feb. 5 rate decision, seeking hints about where borrowing costs might head next

Barclays shares (BARC.L) rose 0.34% to 503.3 pence by 0810 GMT on Wednesday. Traders are gearing up for the bank’s full-year results, due Feb. 10. Investors Chronicle

The stock stayed steady ahead of a packed week for UK rates following Barclays’ completion of a £500 million share buyback, which will reduce its share count. Buybacks occur when a company repurchases its own stock, usually to cut the number of shares outstanding and boost earnings per share.

Barclays confirmed on Monday that it wrapped up the buyback programme announced on Oct. 23, 2025. On Jan. 30, it purchased 1,932,579 shares for cancellation at a volume-weighted average price of 487.5669 pence. The total repurchased shares reached 107,319,865, costing roughly £500 million, according to the filing. Investegate

Barclays reported in a separate statement that as of Jan. 31, it had 13,815,647,298 ordinary shares with voting rights outstanding, and no shares were held in treasury. Investegate

Rate expectations remain subdued as the Bank of England’s Monetary Policy Committee prepares to release its latest decision on Thursday. The Bank Rate stands at 3.75%, per the central bank’s calendar. Bank of England

According to Reuters on Tuesday, the market is pricing in the BoE to keep rates steady at 3.75% this Thursday. Lee Hardman, MUFG’s senior currency analyst, told Reuters, “Markets now think the Bank of England will wait until probably the May policy meeting before cutting rates further.” Reuters

Lenders watch rates closely since shifts can alter the spread between loan earnings and deposit costs — a crucial factor for net interest income. Keeping cuts gradual helps preserve that margin but can put pressure on borrowers.

Barclays’ update on Feb. 10 comes shortly after the BoE decision, offering a snapshot of how the bank is handling margins, costs, and credit quality amid the shifting rate cycle. Investors will also be watching closely to see how the investment bank fares after a rocky start to dealmaking this year.

Still, the buyback isn’t a sure thing for the stock. If the BoE hints at quicker rate cuts or the economy falters with rising bad loans, investors could put more pressure on earnings forecasts and capital buffers.

The BoE decision on Feb. 5 comes first, with Barclays’ full-year results due on Feb. 10. These are the key near-term events poised to shift expectations for Barclays’ share price.

Stock Market Today

  • Cotton Futures Show Mixed Trading as Export Sales Hit Six-Week High
    April 3, 2026, 1:04 AM EDT. Cotton futures displayed mixed movement Thursday, ranging from a 14-point drop to a 4-point gain by midday. The U.S. dollar index rose by 0.347 to 99.805. Crude oil prices jumped $10.54 following President Trump's comments on prolonged Middle East tensions. Export sales of 25/26 cotton hit a six-week high at 371,475 running bales (RB) in the week ending March 26, surpassing last year's levels. New crop sales reached 117,271 RB, the second highest this marketing year. February cotton exports hit a 10-year low for the month at 1.072 million bales but were up 15.51% from January. ICE certified stocks held steady at 114,665 bales. Cotton prices varied with May contract down 8 points at 70.68 cents and July up 4 points at 72.98 cents per pound.
Shell stock jumps after Brazil Orca stake sale, with Q4 results next in focus
Previous Story

Shell stock jumps after Brazil Orca stake sale, with Q4 results next in focus

GSK beats 2025 sales targets — but new CEO warns 2026 growth will cool
Next Story

GSK beats 2025 sales targets — but new CEO warns 2026 growth will cool

Go toTop